We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$95.2M
AUM Growth
+$3.46M
Cap. Flow
+$2.54M
Cap. Flow %
2.66%
Top 10 Hldgs %
72.22%
Holding
42
New
7
Increased
9
Reduced
5
Closed
12

Top Buys

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$7.44M
2
QLTI
QLT Inc
QLTI
+$4.59M
3
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$1.91M
4
ABBV icon
AbbVie
ABBV
+$1.63M
5
AORT icon
Artivion
AORT
+$1.58M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.23M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$3.86M
3
TWM icon
ProShares UltraShort Russell2000
TWM
+$3.51M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$964K
5
DGX icon
Quest Diagnostics
DGX
+$812K

Sector Composition

Rank Sector Weight
1 Healthcare 66.02%
2 Miscellaneous 33.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIRX
26
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$602K 0.63%
952
– –
ALIM
27
DELISTED
Alimera Sciences
ALIM
$461K 0.48%
6,667
– –
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$420K 0.44%
31,250
-31,250
-50% -$383K
STML
29
DELISTED
Stemline Therapeutics, Inc.
STML
$294K 0.31%
25,000
– –
XOMA
30
CALL
DELISTED
Xoma
XOMA
$272K 0.29%
+3,500
New +$252K
AMRN
31
Amarin Corp
AMRN
$297M
– –
-10,000
Closed -$450K
AZN icon
32
CALL
AstraZeneca
AZN
$255B
– –
-150,000
Closed -$10.3M
IMNN icon
33
Imunon
IMNN
$8.98M
– –
-29
Closed -$214K
LGND icon
34
Ligand Pharmaceuticals
LGND
$5.67B
– –
-80,150
Closed -$3.86M
RIGL icon
35
Rigel Pharmaceuticals
RIGL
$875M
– –
-15,000
Closed -$536K
SNY icon
36
CALL
Sanofi
SNY
$107B
– –
-65,000
Closed -$3.21M
TEVA icon
37
CALL
Teva Pharmaceuticals
TEVA
$43.8B
– –
-50,000
Closed -$3.12M
TEVA icon
38
Teva Pharmaceuticals
TEVA
$43.8B
– –
-100,000
Closed -$6.23M
ALIM
39
CALL
DELISTED
Alimera Sciences
ALIM
– –
-3,333
Closed -$251K
AMRI
40
CALL
DELISTED
Albany Molecular Research Inc
AMRI
– –
-120,000
Closed -$2.11M
ARIA
41
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-100,000
Closed -$824K
QLTI
42
CALL
DELISTED
QLT Inc
QLTI
– –
-150,000
Closed -$587K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Healthcare Value Capital held 42 positions worth $95.2M, up 3.8% from $91.8M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Healthcare Value Capital's Q2 2015 filing shows 7 new, 9 increased, 5 reduced and 12 closed positions. Its largest new stake was ANI Pharmaceuticals: 125,000 shares worth $7.76M. The largest sale was Teva Pharmaceuticals, an estimated $6.23M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 61% a quarter earlier, followed by Miscellaneous.

  • Healthcare Value Capital's largest Q2 2015 buy was ANI Pharmaceuticals: 125,000 shares worth $7.76M.
  • Healthcare Value Capital added most to QLT Inc in Q2 2015, an estimated $4.59M increase.
  • Healthcare Value Capital's biggest Q2 2015 reduction was ProShares UltraShort Russell2000, cutting an estimated $3.51M.
  • Healthcare Value Capital fully exited Teva Pharmaceuticals in Q2 2015, selling an estimated $6.23M.
  • Healthcare Value Capital's ten largest holdings make up 72% of its $95.2M portfolio in Q2 2015.
  • Healthcare Value Capital opened 7 new positions and closed 12 in Q2 2015.
  • Healthcare Value Capital's portfolio value rose 3.8% quarter-over-quarter to $95.2M.

Based on Healthcare Value Capital's 13F filing for Q2 2015, filed 14 Aug 2015.